Contact
Please use this form to send email to PR contact of this press release:
ContraVir Pharmaceuticals Completes Final Cohort Dosing in CRV431 Drug-Drug Interaction Study
TO:
Please use this form to send email to PR contact of this press release:
ContraVir Pharmaceuticals Completes Final Cohort Dosing in CRV431 Drug-Drug Interaction Study
TO: